United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

It is hard to get excited after looking at United Therapeutics' (NASDAQ:UTHR) recent performance, when its stock has declined 7.4% over the past three months. However, a closer look at its sound ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be ...

Using the gene-editing technique CRISPR, scientists can modify the pig’s DNA. eGenesis workers make more than 60 edits to help manage a host of potential issues including rejection, size of the organ ...